华润医药今日盘中股价大跌5.02%，引起了市场的广泛关注。
消息面上，此次股价下跌主要与公司旗下多家子公司近期披露的一季度业绩表现分化、整体承压有关。其中，昆药集团一季度营收同比大幅减少48.01%，并出现由盈转亏，净亏损达1.45亿元；华润三九虽然营收同比增长18.60%，但经调整净利润同比下降9.20%，呈现增收不增利的局面。这两家重要子公司的业绩疲软，直接拖累了市场对华润医药集团的整体业绩预期。
相比之下，集团内东阿阿胶和天士力的一季度净利润分别实现了同比增长7.12%和9.78%，表现相对稳健。但昆药集团的显著亏损与华润三九的利润下滑，共同对市场情绪构成了压力，导致股价在交易时段内出现显著下跌。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.